IONIS PHARMACEUTICALS INC — Director's Dealing 2012

Jun 14, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ISIS PHARMACEUTICALS INC (ISIS)
CIK: 0000874015
Period of Report: 2012-06-14

Reporting Person: Geary Richard S (Sr VP, Development)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-06-14	Common Stock	S	1579	$10.86	Disposed	4324	Direct

Footnotes

F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 10/14/2010.